These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38053913)

  • 1. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools.
    Scott JA; Jones AM; Jokl E; Gordon-Walker T; Barry PJ; Hanley NA; Piper Hanley K; Athwal VS
    Heliyon; 2023 Nov; 9(11):e21861. PubMed ID: 38053913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis.
    Calvopina DA; Noble C; Weis A; Hartel GF; Ramm LE; Balouch F; Fernandez-Rojo MA; Coleman MA; Lewindon PJ; Ramm GA
    J Cyst Fibros; 2020 May; 19(3):449-454. PubMed ID: 31303380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
    Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
    Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis.
    Tosco A; Sepe A; Castaldo A; Catzola A; Cimbalo C; Angelini V; Vallone G; Buzzetti R; Raia V; Caprio MG
    Transl Pediatr; 2021 Nov; 10(11):2952-2959. PubMed ID: 34976761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
    Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP
    Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.
    Dana J; Girard M; Franchi-Abella S; Berteloot L; Benoit-Cherifi M; Imbert-Bismut F; Sermet-Gaudelus I; Debray D
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101855. PubMed ID: 34933150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
    Calvopina DA; Lewindon PJ; Ramm LE; Noble C; Hartel GF; Leung DH; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis.
    Lewindon PJ; Puertolas-Lopez MV; Ramm LE; Noble C; Pereira TN; Wixey JA; Hartel GF; Calvopina DA; Leung DH; Ramm GA
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2561-2569.e5. PubMed ID: 30880274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
    Rath T; Hage L; Kügler M; Menendez Menendez K; Zachoval R; Naehrlich L; Schulz R; Roderfeld M; Roeb E
    PLoS One; 2013; 8(3):e58955. PubMed ID: 23516586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
    Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
    Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
    Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T
    Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.
    Squirell E; Lockyer J
    Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease.
    Aqul A; Jonas MM; Harney S; Raza R; Sawicki GS; Mitchell PD; Fawaz R
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):505-511. PubMed ID: 27782957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis related liver disease and endocrine considerations.
    Sherwood JS; Ullal J; Kutney K; Hughan KS
    J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA
    Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
    Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    Klotter V; Gunchick C; Siemers E; Rath T; Hudel H; Naehrlich L; Roderfeld M; Roeb E
    PLoS One; 2017; 12(6):e0178784. PubMed ID: 28575039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators.
    Colombo C; Ramm GA; Lindblad A; Corti F; Porcaro L; Alghisi F; Asherova I; Evans H; Kashirskaya N; Kondratyeva E; Lewindon PJ; de Monestrol I; Oliver M; Ooi CY; Padoan R; Shankar S; Alicandro G
    J Cyst Fibros; 2023 Mar; 22(2):263-265. PubMed ID: 36739240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.
    Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
    PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
    Scott J; Jones AM; Piper Hanley K; Athwal VS
    Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.